ストックスクリーナーアプリを入手
333.47
1.66%
5.45
アフターアワーズ：
335.00
1.53
+0.46%
前日終値:
$328.02
開ける：
$327.84
24時間の取引高:
654.18K
Relative Volume:
1.13
時価総額：
$23.08B
収益：
$2.36B
当期純損益:
$236.10M
株価収益率:
101.48
EPS:
3.286
ネットキャッシュフロー:
$382.50M
1週間 パフォーマンス:
+2.20%
1か月 パフォーマンス:
+4.67%
6か月 パフォーマンス:
+2.69%
1年 パフォーマンス:
+27.92%
1日の値動き範囲:
$324.97
$335.87
1週間の範囲:
$324.75
$341.03
52週間の値動き範囲:
$230.05
$353.50
Insulet Corporation Stock (PODD) Company Profile
PODD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
333.47 | 23.08B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
130.00 | 226.11B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.52 | 137.72B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.80 | 123.49B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
99.22 | 150.85B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
71.02 | 32.17B | 20.25B | 2.29B | 1.40B | 4.8366 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corporation (PODD) 最新ニュース
How analysts revise price targets for Insulet Corporation (GOV) stock2025 Technical Overview & Smart Investment Allocation Tips - newser.com
What machine learning models say about Insulet CorporationWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
Is Insulet Corporation (GOV) stock at risk of policy regulationPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Insulet Corporation stockWeekly Profit Summary & Stepwise Trade Execution Plans - newser.com
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Yahoo Finance
Multi asset correlation models including Insulet CorporationQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Will Insulet Corporation (GOV) stock benefit from Fed rate cutsAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com
Do Options Traders Know Something About Insulet Stock We Don't? - TradingView
Will Insulet Corporation rebound enough to break evenPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Sector ETF performance correlation with Insulet CorporationWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Will Insulet Corporation stock recover after recent dropPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
What technical signals suggest for Insulet Corporation stock2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com
Why Insulet Corporation (GOV) stock stays resilientJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
Best data tools to analyze Insulet Corporation stockJuly 2025 Review & Safe Capital Investment Plans - newser.com
Why Insulet Corporation (GOV) stock could outperform next year2025 Volatility Report & Consistent Growth Stock Picks - newser.com
Why Insulet Corporation stock appeals to dividend seekers2025 Top Decliners & AI Driven Price Predictions - newser.com
Can Insulet Corporation stock sustain revenue growthEarnings Recap Summary & Reliable Entry Point Trade Alerts - newser.com
Will Insulet Corporation outperform the marketMarket Trend Review & Safe Swing Trade Setup Alerts - newser.com
Why Insulet Corporation stock could outperform in 2025July 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
Is Insulet Corporation stock poised for growthWeekly Market Report & Safe Entry Trade Signal Reports - newser.com
Chart based exit strategy for Insulet Corporation2025 Short Interest & Risk Adjusted Swing Trade Ideas - newser.com
How Investors May Respond To Insulet (PODD) Raising Guidance After Omnipod-Driven Q3 Sales Surge - simplywall.st
Insulet Corp (PODD)'s Winning Formula: Financial Metrics and Com - GuruFocus
Why Insulet (PODD) Might be Well Poised for a Surge - sharewise.com
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand - Nasdaq
PODD: BTIG Reiterates Buy Rating with Price Target of $370 | POD - GuruFocus
There May Be Some Bright Spots In Insulet's (NASDAQ:PODD) Earnings - Yahoo Finance
PODD Vs. Intuitive Surgical: This Underdog Might Just Win - Forbes
Zacks.com featured highlights include Insulet, Celestica and Innodata - sharewise.com
Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains - 富途牛牛
Why Insulet Corporation stock is rated strong buyDip Buying & AI Enhanced Trading Alerts - newser.com
How institutional ownership impacts Insulet Corporation stockGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Insulet Corporation (PODD) 財務データ
収益
当期純利益
現金流量
EPS
0.50%
0.00%
大文字化:
|
ボリューム (24 時間):